Statement of Ownership (sc 13g)
03 Julio 2013 - 4:31PM
Edgar (US Regulatory)
CUSIP NO. 577776107 SCHEDULE 13G PAGE 1 OF 11 PAGES
===============================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No.)*
Maxygen, Inc.
-------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.0001 par value
-------------------------------------------------------------------------------
(Title of Class of Securities)
577776107
-------------------------------------------------------------------------------
(CUSIP Number)
June 25, 2013
-------------------------------------------------------------------------------
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Information regarding beneficial ownership is as of July 3, 2013.
|
CUSIP NO. 577776107 SCHEDULE 13G PAGE 2 OF 11 PAGES
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON/S.S. OR I.R.S. IDENTIFICATION
NO. OF ABOVE PERSON
WEISS ASSET MANAGEMENT LP
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [ ]
(B) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
0
NUMBER OF --------------------------------------------------
SHARES 6. SHARED VOTING POWER
BENEFICIALLY
OWNED BY 1,878,759
EACH --------------------------------------------------
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON
WITH: 0
--------------------------------------------------
8. SHARED DISPOSITIVE POWER
1,878,759
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,878,759
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.76%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IA - Investment Adviser
|
CUSIP NO. 577776107 SCHEDULE 13G PAGE 3 OF 11 PAGES
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON/S.S. OR I.R.S. IDENTIFICATION
NO. OF ABOVE PERSON
BIP GP LLC
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [ ]
(B) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
0
NUMBER OF --------------------------------------------------
SHARES 6. SHARED VOTING POWER
BENEFICIALLY
OWNED BY 1,277,554
EACH --------------------------------------------------
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON
WITH: 0
--------------------------------------------------
8. SHARED DISPOSITIVE POWER
1,277,554
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,277,554
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
4.60%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
00 - Limited Liability Company
|
CUSIP NO. 577776107 SCHEDULE 13G PAGE 4 OF 11 PAGES
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON/S.S. OR I.R.S. IDENTIFICATION
NO. OF ABOVE PERSON
WAM GP LLC
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [ ]
(B) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
0
NUMBER OF --------------------------------------------------
SHARES 6. SHARED VOTING POWER
BENEFICIALLY
OWNED BY 1,878,759
EACH --------------------------------------------------
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON
WITH: 0
--------------------------------------------------
8. SHARED DISPOSITIVE POWER
1,878,759
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,878,759
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.76%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
00 - Limited Liability Company
|
CUSIP NO. 577776107 SCHEDULE 13G PAGE 5 OF 11 PAGES
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON/S.S. OR I.R.S. IDENTIFICATION
NO. OF ABOVE PERSON
ANDREW M. WEISS, PH.D.
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [ ]
(B) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
USA
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
0
NUMBER OF --------------------------------------------------
SHARES 6. SHARED VOTING POWER
BENEFICIALLY
OWNED BY 1,878,759
EACH --------------------------------------------------
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON
WITH: 0
--------------------------------------------------
8. SHARED DISPOSITIVE POWER
1,878,759
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,878,759
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.76%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IN - Individual
|
CUSIP NO. 577776107 SCHEDULE 13G PAGE 6 OF 11 PAGES
ITEM 1.
(a) Name of Issuer: Maxygen, Inc.
------------------------------------------------
(b) Address of Issuer's Principal Executive Offices:
411 Borel Avenue, Suite 616
San Mateo, California 94402
------------------------------------------------
ITEM 2.
(a) and (c): Name and Citizenship of Persons Filing:
(i) BIP GP LLC, a Delaware limited liability company ("BIP GP").
(ii) WAM GP LLC, a Delaware limited liability company ("WAM GP")
(iii) Weiss Asset Management LP, a Delaware limited partnership ("Weiss
Asset Management").
(iv) Andrew M. Weiss, Ph.D., a United States citizen ("Andrew Weiss").
(b): Address of Principal Business Office:
BIP GP, WAM GP, Weiss Asset Management, and Andrew Weiss have a business
address of 222 Berkeley St., 16th Floor, Boston, Massachusetts 02116
(d) Title of Class of Securities: Common Stock, $0.0001 par value
-------------------------------------
(e) CUSIP Number: 577776107
------------------
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 13D-2(B), CHECK
WHETHER THE PERSON FILING IS A:
(a) [ ] Broker or Dealer registered under Section 15 of the Act
(15 U.S.C. 78o).
(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) [ ] Insurance Company as defined in section 3(a)(19) of the Act
(15 U.S.C. 78c).
(d) [ ] Investment Company registered under section 8 of the Investment
Company Act of 1940 (15 U.S.C. 80a-8).
(e) [ ] Investment Adviser registered under section 203 of the Investment
Advisers Act or under the laws of any State
(f) [ ] Employee Benefit Plan, Pension fund which is subject to the
provisions of the Employee Retirement Income Security Act of
1974 or Endowment Fund; see Section 240.13d-1(b)(1)(ii)(F)
(g) [ ] A Parent Holding Company or control person, in accordance with
Section 240.13d-1(b)(ii)(G)(Note: See Item 7)
(h) [ ] A Savings Association as defined in Section 3(b) of the Federal
Deposit Insurance Act (12 U.S.C. 1813)
(i) [ ] A Church Plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment
Company Act of 1940 (15 U.S.C. 80a-3)
(j) [ ] Group, in accordance with Section 240.13d-1(b)(1)(ii)(J)
|
CUSIP NO. 577776107 SCHEDULE 13G PAGE 7 OF 11 PAGES
ITEM 4. OWNERSHIP
BIP GP*
(a) Amount Beneficially Owned: 1,277,554
-------------------------------------------
(b) Percent of Class: 4.60%
----------------------------------------------------
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
-----------------------
(ii) shared power to vote or to direct the vote: 1,277,554
---------------------
(iii) sole power to dispose or to direct the disposition of: 0
----------
(iv) shared power to dispose or to direct the disposition of: 1,277,554
---------
WAM GP*
(a) Amount Beneficially Owned: 1,878,759
-------------------------------------------
(b) Percent of Class: 6.76%
----------------------------------------------------
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
-----------------------
(ii) shared power to vote or to direct the vote: 1,878,759
---------------------
(iii) sole power to dispose or to direct the disposition of: 0
----------
(iv) shared power to dispose or to direct the disposition of: 1,878,759
---------
WEISS ASSET MANAGEMENT*
(a) Amount Beneficially Owned: 1,878,759
-------------------------------------------
(b) Percent of Class: 6.76%
----------------------------------------------------
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
-----------------------
(ii) shared power to vote or to direct the vote: 1,878,759
---------------------
(iii) sole power to dispose or to direct the disposition of: 0
----------
(iv) shared power to dispose or to direct the disposition of: 1,878,759
---------
|
CUSIP NO. 577776107 SCHEDULE 13G PAGE 8 OF 11 PAGES
ANDREW M. WEISS, PH.D.*
(a) Amount Beneficially Owned: 1,878,759
-------------------------------------------
(b) Percent of Class: 6.76%
----------------------------------------------------
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
------------------------
(ii) shared power to vote or to direct the vote: 1,878,759
-----------------------
(iii) sole power to dispose or to direct the disposition of: 0
----------
(iv) shared power to dispose or to direct the disposition of: 1,878,759
----------
-----------------------
* Shares reported for BIP GP include shares beneficially owned by a private
investment partnership (the "Partnership") of which BIP GP is the sole general
partner. Weiss Asset Management is the sole investment manager to the
Partnership and a private investment company (the "Company"). WAM GP is the
sole general partner of Weiss Asset Management. Andrew Weiss is the managing
member of WAM GP and BIP GP. Shares reported for WAM GP, Andrew Weiss and Weiss
Asset Management include shares beneficially owned by the Partnership (and
reported above for BIP GP) and the Company.
Each of BIP GP, WAM GP, Weiss Asset Management and Andrew Weiss disclaims
beneficial ownership of the shares reported herein as beneficially owned by each
except to the extent of their respective pecuniary interest therein. The percent
of class computations are based on 27,792,520 shares of Common Stock, $0.0001
par value issued and outstanding as of May 31, 2013, as reported in the 8-K
filed with the SEC on June 3, 2013.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following [].
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not Applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL
PERSON
Not Applicable
|
CUSIP NO. 577776107 SCHEDULE 13G PAGE 9 OF 11 PAGES
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Not Applicable
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not Applicable
ITEM 10. CERTIFICATION
By signing below, I certify that, to the best of my knowledge and belief, the
securities referred to above were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the issuer of
the securities and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
ITEM 11. MATERIALS TO BE FILED AS EXHIBITS
Exhibit 1 Joint Filing Agreement
|
CUSIP NO. 577776107 SCHEDULE 13G PAGE 10 OF 11 PAGES
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I hereby
certify that the information set forth in this statement is true, complete and
correct.
Dated: July 3, 2013
WEISS ASSET MANAGEMENT LP
By: /s/ Daniel Bradford
-----------------------------------
Daniel Bradford, General Counsel
BIP GP LLC
By: /s/ Daniel Bradford
-----------------------------------
Daniel Bradford, General Counsel
WAM GP LLC
By: /s/ Daniel Bradford
-----------------------------------
Daniel Bradford, General Counsel
ANDREW M. WEISS, PH.D.
By: /s/ Daniel Bradford
-----------------------------------
Daniel Bradford, Attorney-in-Fact for Andrew Weiss
|
CUSIP NO. 577776107 SCHEDULE 13G PAGE 11 OF 11 PAGES
Exhibit 1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of
1934, as amended, Weiss Asset Management LP, BIP GP LLC, WAM GP LLC and Andrew
M. Weiss, hereby agree to the joint filing on behalf of each of them of a
statement on Schedule 13G and/or 13D (including any and all amendments thereto)
with respect to the Common Stock, $0.0001 par value, of Maxygen, Inc., and
further agree that this Joint Filing Agreement, as may be amended from time to
time, shall be included as an Exhibit to such joint filings.
The undersigned further agree that each party hereto is responsible for
the timely filing of such Statement on Schedule 13G and/or 13D and any
amendments thereto, and for the accuracy and completeness of the information
concerning such party contained therein; provided, however, that no party is
responsible for the accuracy or completeness of the information concerning any
other party, unless such party knows or has reason to believe that such
information is inaccurate.
This Joint Filing Agreement may be signed in counterparts with the same
effect as if the signature on each counterpart were upon the same instrument.
IN WITNESS WHEREOF, the undersigned have executed this Agreement as of
July 3, 2013.
WEISS ASSET MANAGEMENT LP
By: /s/ Daniel Bradford
-----------------------------------
Daniel Bradford, General Counsel
BIP GP LLC
By: /s/ Daniel Bradford
-----------------------------------
Daniel Bradford, General Counsel
WAM GP LLC
By: /s/ Daniel Bradford
-----------------------------------
Daniel Bradford, General Counsel
Andrew M. Weiss
By: /s/ Daniel Bradford
-----------------------------------
Daniel Bradford, Attorney-in-Fact for Andrew M. Weiss
|
Maxygen, Inc. (MM) (NASDAQ:MAXY)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Maxygen, Inc. (MM) (NASDAQ:MAXY)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
Real-Time news about Maxygen, Inc. (MM) (NASDAQ): 0 recent articles
Más de Maxygen Inc Artículos de Noticias